Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Thiopental Sodium bulk supplier for pharma manufacturers

Thiopental Sodium 500 mg, 1g Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 500 mg, 1g

Reference Brands: Pentothal (USA/EU)

Category: Anaesthetics

Ultra-short-acting barbiturate anesthetic for induction of general anesthesia, seizure control, or intracranial pressure management; rapid onset (~30–45 seconds), short duration (5–10 minutes).

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Thiopental Sodium — third party manufacturing & bulk supply

Thiopental Sodium 500 mg, 1g is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Thiopental Sodium is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Thiopental Sodium listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Thiopental Sodium →
Back to Listing

Frequently Asked Questions

Thiopental Sodium is used as a short-acting barbiturate general anesthetic for the induction of anesthesia prior to surgical procedures. It is also used to induce medical comas, control intracranial pressure, and as an adjunct in the treatment of seizures.

Thiopental Sodium is made from the active ingredient Thiopental sodium, a barbiturate compound that works by depressing the central nervous system and enhancing the effects of gamma-aminobutyric acid (GABA), leading to sedation, hypnosis, and anesthesia.

The trade names of Thiopental Sodium include Pentothal and Nesdonal.

Thiopental Sodium has been manufactured by companies such as Hospira (a Pfizer company), Abbott Laboratories, and Sandoz.

The generic name of Thiopental Sodium is Thiopental sodium.

The brand names of Thiopental Sodium are Pentothal and Nesdonal.

Thiopental Sodium is manufactured in the United States, the United Kingdom, and various EU countries by GMP-certified pharmaceutical manufacturers specializing in anesthetic agents.

Related Products

Methohexital Sodium

Strength:
500mg/ 1g

Form: Injection

Reference Brands: Brevital Sodium (USA/EU/UK)

View Details
Desflurane

Strength:
100% (240 mL bottle)

Form: Inhalation Liquid (for vaporizer use)

Reference Brands: Suprane (USA/EU/UK)

View Details
Halothane

Strength:
100% Halothane

Form: Inhalation Liquid (for vaporizer use)

Reference Brands: Fluothane

View Details
Prilocaine

Strength:
10mg/ml, 20mg/ml, 30mg/ml

Form: Injection

Reference Brands: Citanest (EU/UK)

View Details
Ropivacaine

Strength:
0.2% (2 mg/mL), 0.5% (5 mg/mL), 0.75% (7.5 mg/mL), 1.0% (10 mg/mL)

Form: Injection

Reference Brands: Naropin (US & EU)

View Details
Procaine Generics

Strength:
0.5%, 1%, 2% and 10%

Form: Injection

Reference Brands: Novocain, Procainum(EU & US)

View Details
Tetracaine Hcl

Strength:
1%

Form: injection

Reference Brands: Generic formulations marketed under different names

View Details
Etidocaine

Strength:
1% ,1.5% , 2%

Form: Injection

Reference Brands: Duranest (USA/EU/UK)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.